Chun‐Yen Lin

7.4k citations

209 papers · 5.3k indexed · h-index 41

Impact in

Hepatology top 0.5%
- Hepatitis C virus research
- Liver Disease and Transplantation
Immunology top 1%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology
- Immunotherapy and Immune Responses

Papers in

Hepatology 78
- Hepatitis C virus research 40
- Hepatocellular Carcinoma Treatment and Prognosis 27
- Liver Disease and Transplantation 19
Immunology 54
- Immune Cell Function and Interaction 34
- T-cell and B-cell Immunology 23
- Immunotherapy and Immune Responses 19

Co-authors: Herman Waldmann Stephen Cobbold Luís Graça I‐Shyan Sheen Ching‐Tai Huang Elizabeth Adams J. B. Rattner Yung‐Chang Lin
Journals: PLoS ONE (9 papers)The Journal of Immunology (8 papers)Scientific Reports (7 papers)Journal of Viral Hepatitis (6 papers)Journal of Gastroenterology and Hepatology (4 papers)
Partner nations: Taiwan United States United Kingdom

In The Last Decade

Chun‐Yen Lin

199 papers receiving 5.2k citations

Peers

Countries citing papers authored by Chun‐Yen Lin

Since Specialization

Citations

This map shows the geographic impact of Chun‐Yen Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Chun‐Yen Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Chun‐Yen Lin more than expected).

Fields of papers citing papers by Chun‐Yen Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Chun‐Yen Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Chun‐Yen Lin. The network helps show where Chun‐Yen Lin may publish in the future.

Co-authors

The 25 scholars most cited alongside Chun‐Yen Lin, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Chun‐Yen Lin Line = papers co-authored together Chun‐Yen Lin links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Significant Decline in HCV ‐Related Mortality From Liver Cirrhosis and Chronic Liver Disease (2015–2022): A Sentinel Center Study Liver International ·Cheng‐Yeh Yang, Chih‐Yun Lin, Jing‐Houng Wang, Chun‐Yen Lin, Rong‐Nan Chien, Sheng‐Nan Lu	2025	0
2	LAG ‐3 ⁺ Regulatory T Cells Suppress Effector Function of T Cells and Allow Their Proliferation Into Regulatory T Cells Immunology ·Avijit Dutta, Shi‐Chuen Miaw, Tse‐Ching Chen, Chia‐Shiang Chang, Yulin Huang, Yung‐Chang Lin, Chun‐Yen Lin, Ching‐Tai Huang	2025	0
3	Prognostic potential of neutrophil-to-lymphocyte ratio for appendicular skeletal muscle mass reduction in males aged 70 and older Aging ·Ying‐Jen Chen, Chieh‐Li Yen, C H Lee, Kuo‐Chen Liao, Ji-Tseng Fang, Tz-Shiu Tsai, Yi-Ching Chen, Chun‐Yen Lin	2025	1
4	Hepatocellular Carcinoma Incidences and Risk Factors in Hepatitis C Patients: Interferon versus Direct-Acting Agents Viruses ·Yuting Kao, Yen‐Chun Liu, Yating Cheng, Yu‐Wen Wen, Yi‐Chung Hsieh, Cheng-Er Hsu, Chung‐Wei Su, Jennifer Tai, Yi‐Cheng Chen, Wen‐Juei Jeng, Chun‐Yen Lin, Rong‐Nan Chien, Dar‐In Tai, I-Shyan Sheen	2024	2
5	Comparing Lenvatinib/Pembrolizumab with Atezolizumab/Bevacizumab in Unresectable Hepatocellular Carcinoma: A Real-World Experience with Propensity Score Matching Analysis Cancers ·Yu-Chun Hsu, Po‐Ting Lin, Wei Teng, Yi‐Chung Hsieh, Wei‐Ting Chen, Chung‐Wei Su, Ching‐Ting Wang, Pei‐Mei Chai, Chen‐Chun Lin, Chun‐Yen Lin, Shi‐Ming Lin, (unknown), (unknown)	2024	4
6	Photopolymerizable Hydrogel for Enhanced Intramyocardial Vascular Progenitor Cell Delivery and Post‐Myocardial Infarction Healing Advanced Healthcare Materials ·Xuechong Hong, Allen Chilun Luo, Ilias P. Doulamis, Nicholas Oh, Gwang‐Bum Im, Chun‐Yen Lin, Pedro J. del Nido, Ruei‐Zeng Lin, Juan M. Melero‐Martin	2023	11
7	An IL-17-EGFR-TRAF4 axis contributes to the alleviation of lung inflammation in severe influenza Communications Biology ·Avijit Dutta, Chen‐Yiu Hung, Tse‐Ching Chen, Sung-Han Hsiao, Chia‐Shiang Chang, Yung‐Chang Lin, Chun‐Yen Lin, Ching‐Tai Huang	2023	4
8	The origin of regulatory from the effector cells in LAG‐3‐marked Th1 immunity against severe influenza virus infection Immunology ·Avijit Dutta, Chen‐Yiu Hung, Tse‐Ching Chen, Chia‐Shiang Chang, Sung‐Han Hsiao, Yung‐Chang Lin, Chun‐Yen Lin, Ching‐Tai Huang	2022	3
9	Similar efficacy and safety between lenvatinib versus atezolizumab plus bevacizumab as the first‐line treatment for unresectable hepatocellular carcinoma Cancer Medicine ·Chung‐Wei Su, Wei Teng, Po‐Ting Lin, Wen‐Juei Jeng, K.F. Chen, Yi‐Chung Hsieh, Wei‐Ting Chen, M. Ho, Chia‐Hsun Hsieh, Ching‐Ting Wang, Pei‐Mei Chai, Chen‐Chun Lin, Chun‐Yen Lin, Shi‐Ming Lin	2022	17
10	Effect of [6]-gingerol on viral neuraminidase and hemagglutinin-specific T cell immunity in severe influenza Phytomedicine Plus ·Avijit Dutta, Sung-Han Hsiao, Chen‐Yiu Hung, Chia‐Shiang Chang, Yung‐Chang Lin, Chun‐Yen Lin, Tse‐Ching Chen, Ching‐Tai Huang	2022	4
11	IDDF2021-ABS-0079 Switching from tenofovir disoproxil fumarate (TDF) and/or other oral antivirals (OAVS) to tenofovir alafenamide (TAF) in virally suppressed chronic hepatitis B (CHB) patients with hepatic impairment: final 2-year efficacy and safety results from a phase 2 Young‐Suk Lim, Chun‐Yen Lin, Jeong Heo, Ho Bae, Wan‐Long Chuang, Tak Yin Owen Tsang, Claire Fournier, Aric J. Hui, Huy Trinh, Carol Yee Kwan Chan, Susanna K. Tan, Yang Zhao, John F. Flaherty, Vithika Suri, Anuj Gaggar, D. Brainard, Stephen Ryder, Harry L.A. Janssen	2021	1
12	Highly efficient and tumor-selective nanoparticles for dual-targeted immunogene therapy against cancer Science Advances ·Kuan‐Wei Huang, Fu‐Fei Hsu, Jian‐Tai Qiu, Guann-Jen Chern, Yi-An Lee, Chih‐Chun Chang, Yu‐Ting Huang, Yun‐Chieh Sung, Cheng-Chin Chiang, Rui-Lin Huang, Chu-Chi Lin, Trinh Kieu Dinh, Hsi‐Chien Huang, Yu-Chuan Shih, Donia Alson, Chun‐Yen Lin, Yung‐Chang Lin, Po-Chiao Chang, Shu‐Yi Lin, Yunching Chen	2020	213
13	Postembolization fever after transarterial chemoembolization is a sign of unfavorable therapeutic response in hepatocellular carcinoma patients Advances in digestive medicine ·Chien‐Wei Peng, Wei Teng, Yi‐Chung Hsieh, Wen‐Juei Jeng, Chien‐Hao Huang, Kar‐Wai Lui, Chen‐Fu Hung, Yi‐Cheng Chen, Chen‐Chun Lin, (unknown), Chun‐Yen Lin, Shi‐Ming Lin, I‐Shyan Sheen	2020	2
14	In HCV-related liver cirrhosis, local pulse wave velocity increases and in decompensated patients correlates with poorer survival PLoS ONE ·Chien‐Hao Huang, Lung‐Sheng Wu, Wen‐Juei Jeng, Yu-Fu Cheng, Yu‐Shien Ko, I‐Shyan Sheen, Chun‐Yen Lin	2019	11
15	Real-world safety and efficacy of paritaprevir/ritonavir/ombitasvir plus dasabuvir ± ribavirin in patients with hepatitis C virus genotype 1 and advanced hepatic fibrosis or compensated cirrhosis: a multicenter pooled analysis Scientific Reports ·Chun‐Hsien Chen, Chien‐Hung Chen, Chih‐Lang Lin, Chun‐Yen Lin, Tsung‐Hui Hu, Shui‐Yi Tung, Sen‐Yung Hsieh, Sheng‐Nan Lu, Rong‐Nan Chien, Chao‐Hung Hung, I‐Shyan Sheen	2019	9
16	LAP+CD4+ T Cells Are Suppressors Accumulated in the Tumor Sites and Associated with the Progression of Colorectal Cancer Clinical Cancer Research ·Jayashri Mahalingam, Yung‐Chang Lin, Jy‐Ming Chiang, Po‐Jung Su, Jian‐He Fang, Yu‐Yi Chu, Ching‐Tai Huang, Cheng-Tang Chiu, Chun‐Yen Lin	2012	14
17	Tumor-Derived Chemokine CCL5 Enhances TGF-β–Mediated Killing of CD8+ T Cells in Colon Cancer by T-Regulatory Cells Cancer Research ·Li-Yuan Chang, Yung‐Chang Lin, Jayashri Mahalingam, Ching‐Tai Huang, Ten-Wen Chen, Chiao-Wen Kang, Huimin Peng, Yu‐Yi Chu, Jy-Ming Chiang, Avijit Dutta, Yuan‐Ji Day, Tse‐Ching Chen, Chau‐Ting Yeh, Chun‐Yen Lin	2012	189
18	18F-FDG PET Can Replace Conventional Work-up in Primary M Staging of Nonkeratinizing Nasopharyngeal Carcinoma Journal of Nuclear Medicine ·Feng‐Yuan Liu, Chun‐Yen Lin, J. Chang, S.-H. Ng, Shy‐Chyi Chin, H.-M. Wang, Chun‐Ta Liao, S.-C. Chan, Tzu‐Chen Yen	2007	66
19	Occurrence of bacterial leaf spot of betel palm caused by Burkholderia andropogonis and inhibition of bacterial growth by agrochemicals. Zhíwù bìnglǐxué huìkān ·S. H. Hseu, W. C. Lai, Yiting Pan, Chun‐Yen Lin	2007	3
20	Contributions of bone maturation measurements to the differential diagnosis of neonatal transient hypothyroidism versus dyshormonogenetic congenital hypothyroidism Acta Paediatrica ·DM Niu, B. Hwang, CM Tiu, LP Tsai, JL Yen, Lee Nc, Chun‐Yen Lin	2004	2

About Chun‐Yen Lin

Chun‐Yen Lin is a scholar working on Hepatology, Immunology, Epidemiology, Oncology and Transplantation, having authored 209 papers that have together received 5.3k indexed citations. Recurring topics across this work include Liver Disease Diagnosis and Treatment (52 papers), Hepatitis C virus research (40 papers), Hepatitis B Virus Studies (37 papers), Immune Cell Function and Interaction (34 papers), Hepatocellular Carcinoma Treatment and Prognosis (27 papers), T-cell and B-cell Immunology (23 papers), Liver Disease and Transplantation (19 papers) and Immunotherapy and Immune Responses (19 papers). The work is most often cited by research in Hepatology (1.0k citations), Immunology (1.7k citations), Transplantation (103 citations), Epidemiology (1.2k citations) and Oncology (888 citations). Chun‐Yen Lin has collaborated with scholars based in Taiwan, United States and United Kingdom. Frequent co-authors include Herman Waldmann, Stephen Cobbold, Luís Graça, I‐Shyan Sheen, Ching‐Tai Huang, Elizabeth Adams, J. B. Rattner, Yung‐Chang Lin, Tse‐Ching Chen and Yung‐Chang Lin. Their work appears in journals such as PLoS ONE, The Journal of Immunology, Scientific Reports, Journal of Viral Hepatitis and Journal of Gastroenterology and Hepatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact